Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT ‐1 study
Diabetes, Obesity and Metabolism · 2025-02 · 27 (2) · 539-550
DOI: 10.1111/dom.16046 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 04.11.2024. Verfasst von Kimberly A Gudzune und 6 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Obesity, Patient Reported Outcome Measures, Quality of Life, Weight Loss. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Aims
The SURMOUNT‐1 trial investigated effects of tirzepatide, a glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist, on body weight in participants with obesity or overweight. This analysis evaluated changes in patient‐reported outcomes (PROs) assessing physical function, psychosocial well‐being, and overall health aspects of participants' health‐related quality of life (HRQoL) in SURMOUNT‐1.
Methods
PRO instruments included the Impact of Weight on Quality of Life‐Lite Clinical Trials version (IWQOL‐Lite‐CT), Short Form Survey‐36 version 2 (SF‐36v2) and EQ‐5D‐5L. Scores were analysed by treatment group and by categorical degree of weight reduction group: >0 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Eli Lilly and Company, Indianapolis, Indiana, USA.
Förderung
- Eli Lilly and Company
Zitieren
APA
Gudzune, K. A., Stefanski, A., Cao, D., Mojdami, D., Wang, F., Ahmad, N., & Ling Poon, J. (2025). Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT ‐1 study. Diabetes, Obesity and Metabolism, 27(2), 539-550. https://doi.org/10.1111/dom.16046
Vancouver
Gudzune KA, Stefanski A, Cao D, Mojdami D, Wang F, Ahmad N, et al. Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT ‐1 study. Diabetes, Obesity and Metabolism. 2025;27(2):539-550. doi:10.1111/dom.16046
BibTeX
@article{Gudzune2025,
author = {Gudzune, Kimberly A and Stefanski, Adam and Cao, Dachuang and Mojdami, Donna and Wang, Fangyu and Ahmad, Nadia and Ling Poon, Jiat},
title = {Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT ‐1 study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {2},
pages = {539--550},
doi = {10.1111/dom.16046}
}
EUVIMED